Kiniksa Pharmaceuticals
KNSA
KNSA
77 hedge funds and large institutions have $274M invested in Kiniksa Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 23 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
4% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 23
Holders
77
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$34.7M | |
| 2 | +$11.8M | |
| 3 | +$7.67M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$5.56M |
| 5 |
SCA
Spearhead Capital Advisors
Wellington,
Florida
|
+$4.19M |
Top Sellers
| 1 | -$15.6M | |
| 2 | -$7.72M | |
| 3 | -$4.29M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$3.67M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$3.25M |